Many children discontinuing use of ADHD medication

December 15, 2006

Conway, Ark. - December 15, 2006 - Social stigma and feeling lifeless and/or alienated from one's peers are some of the reasons why children and adolescents stop taking prescription stimulant medications used to treat attention deficit-hyperactivity disorder (ADHD), according to a new study published in the Journal for Specialists in Pediatric Nursing.

ADHD is a common neurobehavioral disorder, affecting 4.4 million children in the United States between the ages of 4 and 17. Following diagnosis, 56% are treated with prescription stimulant medications. According to the study, many stop using these medications even while they are still exhibiting symptoms of the disorder, despite research indicating these medications are effectively reducing hyperactivity, impulsivity and inattention.

The study also found that while ADHD is a chronic disorder, none of the adolescents interviewed had received ongoing education about their condition. As college students, many used the medications irregularly, sometimes in doses exceeding the prescribed amount, and often at night - factors that may exacerbate the side effects.

Julie B. Meaux, PhD, RNC, lead author of the study, suggests that "dialogue between the child, parents and healthcare provider about the general effects, side effects and potential abuse of prescribed stimulant medications is essential," adding "careful administration of dosages, based on input from the child, is exceedingly important."
-end-
This study is published in the current issue of the Journal for Specialists in Pediatric Nursing. Media wishing to receive a PDF of this article may contact professionalnews@bos.blackwellpublishing.net

Julie B. Meaux, PhD, RNC is an Assistant Professor in the Department of Nursing at University of Central Arkansas. She can be reached for questions at juliem@mail.uca.edu.

The Journal for Specialists in Pediatric Nursing bridges the gap between research and practice by publishing peer-reviewed reliable, clinically relevant, and readily applicable evidence. The journal integrates the best evidence with pediatric nurses' passion for achieving the best outcomes. For more information, please visit www.blackwellnursing.com/jspn.

Blackwell Publishing is the world's leading society publisher, partnering with 665 medical, academic, and professional societies. Blackwell publishes over 800 journals and has over 6,000 books in print. The company employs over 1,000 staff members in offices in the US, UK, Australia, China, Singapore, Denmark, Germany, and Japan. Blackwell's mission as an expert publisher is to create long-term partnerships with our clients that enhance learning, disseminate research, and improve the quality of professional practice. For more information on Blackwell Publishing, please visit www.blackwellpublishing.com or www.blackwell-synergy.com.

Blackwell Publishing Ltd.

Related ADHD Articles from Brightsurf:

Autism and ADHD share genes
Researchers from the national psychiatric project iPSYCH have found that autism and ADHD share changes in the same genes.

ADHD across racial/ethnic groups
This study of patients from diverse racial/ethnic backgrounds who received care at the Kaiser Permanente Northern California health system looked at how common attention-deficit/hyperactivity disorder (ADHD) diagnoses were over a 10-year period across seven racial/ethnic groups.

Cycles of reward: New insight into ADHD treatment
Researchers at the Okinawa Institute of Science and Technology Graduate University (OIST) in collaboration with scientists at the University of Otago and the University of Auckland in New Zealand, investigated the actions of the drug in rats.

Young mums more likely to have kids with ADHD
Young mothers have a greater chance of having a child with attention deficit hyperactivity disorder (ADHD) according to new research from the University of South Australia.

ADHD medication: How much is too much for a hyperactive child?
When children with ADHD don't respond well to Methylphenidate (MPH, also known as Ritalin) doctors often increase the dose.

Antipsychotic use in youths with ADHD is low, but still cause for concern
A new study eased fears about the proportion of youths with ADHD taking antipsychotic drugs, but still found that many prescriptions may be inappropriate.

How stimulant treatment prevents serious outcomes of ADHD
Analysis quantifies the extent which stimulant treatment reduces serious outcomes in children and young adults with ADHD.

Did Leonardo da Vinci have ADHD?
Leonardo da Vinci produced some of the world's most iconic art, but historical accounts show that he struggled to complete his works.

More sleep may help teens with ADHD focus and organize
Teenagers with attention deficit hyperactivity disorder (ADHD) may benefit from more sleep to help them focus, plan and control their emotions.

Researchers have found the first risk genes for ADHD
A major international collaboration headed by researchers from the Danish iPSYCH project, the Broad Institute of Harvard and MIT, Massachusetts General Hospital, SUNY Upstate Medical University, and the Psychiatric Genomics Consortium has for the first time identified genetic variants which increase the risk of ADHD.

Read More: ADHD News and ADHD Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.